Judith Scaglione
Family · South Miami, FLNPI 1831370386
Payments from drug & device makers
Across 329 payments — averaging $38.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vifor Pharma, Inc.$3K
- Calliditas Therapeutics US Inc.$3K
- Amgen$1K
- Fresenius USA Marketing, Inc.$1K
- AstraZeneca$787
- Mallinckrodt Hospital Products Inc.$750
- plus $3K from 16 others
What the payments were for
- Consulting fees$2,14817%
- Food & beverage$10,17981%
- Education$2162%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vifor Pharma, Inc. | 117 | $3,491 |
| Calliditas Therapeutics US Inc. | 10 | $2,535 |
| Amgen(2 entities) | 32 | $1,122 |
| Fresenius USA Marketing, Inc. | 24 | $1,092 |
| AstraZeneca | 19 | $787 |
| Mallinckrodt Hospital Products Inc. | 26 | $750 |
| Otsuka America Pharmaceutical, Inc. | 18 | $525 |
| Ardelyx, Inc. | 13 | $345 |
| Aurinia Pharma U.S., Inc. | 12 | $299 |
| GSK | 7 | $295 |
| Travere Therapeutics, Inc. | 11 | $262 |
| Akebia Therapeutics Inc | 7 | $248 |
| Boehringer Ingelheim | 8 | $221 |
| Novartis | 5 | $137 |
| Bayer | 5 | $109 |
| Novo Nordisk | 5 | $105 |
| OPKO Pharmaceuticals, LLC | 3 | $59 |
| Lilly USA, LLC | 2 | $46 |
| Daiichi Sankyo Inc. | 2 | $41 |
| Cormedix Inc. | 1 | $26 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Scpharmaceuticals Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,542 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VelphoroSucroferric Oxyhydroxide | 88 | $212,363 |
| VeltassaPatiromer Calcium Sorbitex | 110 | $90,580 |
| AuryxiaFerric Citrate | 63 | $74,883 |
| XphozahTenapanor Hcl | 12 | $57,505 |
| FarxigaDapagliflozin Propanediol | 43 | $46,710 |
| Sevelamer Carbonate | 115 | $25,035 |
| ProcritEpoetin Alfa | 17 | $20,265 |
| EliquisApixaban | 17 | $14,265 |
| JardianceEmpagliflozin | 14 | $11,087 |
| RetacritEpoetin Alfa-Epbx | 34 | $9,505 |
| LokelmaSodium Zirconium Cyclosilicate | 13 | $7,076 |
| Nifedipine ErNifedipine | 68 | $3,644 |
| Midodrine Hcl | 15 | $1,159 |
| Calcium Acetate | 19 | $1,134 |
| Bumetanide | 39 | $1,054 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Fresenius USA Marketing, Inc.Velphoro | $1,092 | $212,36388 claims |
| Akebia Therapeutics IncAuryxia | $248 | $74,88363 claims |
| AstraZenecaFarxiga, Lokelma | $787 | $53,78556 claims |
| Boehringer IngelheimJardiance | $221 | $11,08714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 14,618 family providers in Florida.
Other family in South Miami
- Darlena BanasSouth Miami$64K
- Naime Reyno RamosSouth Miami$44K
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.